This dataset is from the SAFE study, focusing on developing and evaluating an eHealth intervention for women in the Netherlands who experience intimate partner violence and abuse (IPVA). The first goal was to assess needs, wishes and obstacles with regard to an eHealth intervention in the context of IPVA and to develop an eHealth intervention for women who experience IPVA. This, together with scientific literature and similar interventions in the IPVA context, inspired the content and functionalities of the SAFE intervention. Then, we aimed for the intervention to increase self-efficacy, awareness and perceived support and to decrease anxiety and depression symptoms amongst its users: women (18-50 years old) who experience IPVA. Also, we aimed for the intervention to encourage women in help seeking, and that the intervention would be a suitable tool to deliver information and support its users.For the development phase, we interviewed women IPVA victims/survivors (18+) and professionals in the field of domestic violence and abuse (DVA) and IPVA (N=16; published study: https://journals.sagepub.com/doi/10.1177/08862605211036108). The eHealth intervention SAFE was launched in April 2019 and simultaneously gathering data for the RCT and process evaluation, aimed at evaluating the intervention, started. For the RCT, after the participant gave their consent (digitally), we followed women (18-50 years old) for 6 or 12 months (depending on when they were included; see protocol article for more info: https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-020-08743-0) and gathered data on multiple timepoints: baseline (M0/T0, at registration; N=198), 3 months (M3/T1), 6 months (M6/T2), and 12 months (M12/T3). The RCT study had two study arms: control group and intervention group. With the intervention group receiving a more elaborate and interactive intervention than the control group (see protocol article for additional information on the content of the intervention). All RCT data was gathered online, with questionnaires on demographic data, on their IPVA experience, and with the primary outcome being self-efficacy at M6 (measured with the General Self-Efficacy Scale (GSE)). Examples of secondary outcomes are anxiety and depression (measured with the Hospital Anxiety and Depression Scale (HADS)). The process evaluation included quantitative and qualitative data. Quantitative from the Web Evaluation Questionnaire (WEQ) that assessed how users graded the intervention, if they felt it was safe and easy to use etc. WEQ data was gathered at one month after the first login (M1), 3 months (M3) and 6 months (M6) after registering for SAFE. The qualitative data consists of interviews with participants from the RCT intervention study arm: N=10. The semi-structured interviews focused on the users' experiences with and opinions on the SAFE eHealth intervention.Data are in Dutch. Two sets of interview data: one from the development phase and one from the process evaluation. Two Excel documents with the final codebooks for the two interview studies. Two SPSS datasets for the RCT and process evaluation. Data are anonymized and pseudonymized to ensure the participants' safety and privacy. All participants provided (digital) informed consent before participating.- Interview data development phase (with survivors / victims and professionals): gathered in 2018, in person interviews, N=16. Publication: https://journals.sagepub.com/doi/10.1177/08862605211036108- Interview data process evaluation (with participants from the RCT intervention study arm): gathered in 2021, online interviews, N=10. No publication yet.- SPSS data RCT (with a control and intervention study arm): gathered in 2019-2021, via online questionnaires (e.g. demographic data, General Self-Efficacy Scale, Hospital Anxiety and Depression Scale, Bem Sex Role Inventory, Medical Outcomes Study Social Support 5), N=198 at baseline. No publication yet. Protocol: https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-020-08743-0- SPSS data process evaluation: gathered in 2019-2021, via online questionnaire (Web evaluation questionnaire). No publication yet. Protocol: https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-020-08743-0Methodology interview data: semi-structured interviews, open thematic coding in Atlas.ti, with 2 or 3 researchers coding independently, qualitative content analysis, grounded theory.Methodology questionnaire data: use of validated questionnaires, analyzing in SPSS: descriptive statistics, check for selective attrition bias, T-tests, ANCOVA, GEE.

Data from the development process (interviews), RCT and process evaluation